SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT02807181 · TERMINATED
Trial details
- NCT number
- NCT02807181
- Sponsor
- Sirtex Medical
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2021-04-29
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.